ABEONA THERAPEUTICS INC. Gain (Loss) on Extinguishment of Debt
ABEONA THERAPEUTICS INC. (ABEO) reported Gain (Loss) on Extinguishment of Debt of $11.63 million for the 0-month period ending 2007-11-07, per its 10-K filed 2014-03-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2014-03-26
- 2007-11-07: Gain (Loss) on Extinguishment of Debt 0 month $11.63M.
| Period end | Gain (Loss) on Extinguishment of Debt 0 month |
|---|---|
| 2007-11-07 | $11.63M 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |